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A B S T R A C T
Posterior Reversible Encephalopathy Syndrome (PRES) is a syndrome comprising headache, altered
mentation, and seizures, associated with neuroimaging ﬁndings characteristic of subcortical edema in
the posterior regions. It is usually seen in patients treated with immunosuppressants, in renal failure, or
with eclampsia. Recurrent episodes of PRES in the same patient are rarely observed. Although seizures
are often seen in PRES, EEG ﬁndings are not well described and include generalized and focal slowing
with epileptiform discharges; there are limited reports of Periodic Lateralized Epileptiform Discharges
(PLEDs) occurring during PRES, and there are no reports of PRES associated with PLEDs with subsequent
development of epilepsy. We report a patient we followed for one year with recurrent episodes of PRES
associated with posteriorly dominant independent bilateral PLEDs who subsequently developed
epilepsy. Patients with PRES and PLEDs should be treated aggressively with anti-hypertensive and anti-
epileptic agents in order to avoid potential complications. Although PRES is typically thought of as a
reversible syndrome, this case illustrates that PRES may have serious long term sequelae after the
reversible syndrome has resolved. This case highlights the importance of aggressive management of
PRES as well as the prevention of subsequent episodes of PRES as patients may develop permanent brain
dysfunction.
Published by Elsevier Ireland Ltd on behalf of British Epilepsy Association.
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Posterior Reversible Encephalopathy Syndrome (PRES) is a
syndrome comprising headache, altered mentation, and seizures,
associated with neuroimaging ﬁndings characteristic of subcorti-
cal edema in the posterior regions. It is usually seen in patients
treated with immunosuppressants, in renal failure, or with
eclampsia. Recurrent episodes of PRES in the same patient are
rarely observed. Although seizures are often seen in PRES, EEG
ﬁndings are not well described and include generalized and focal
slowing with epileptiform discharges; there are limited reports of
Periodic Lateralized Epileptiform Discharges (PLEDs) occurring
during PRES, and there are no reports of PRES associated with
PLEDs with subsequent development of epilepsy.
2. Case report
A twenty-eight-year old man with no prior medical history
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Thrombocytopenic Purpura–Hemolytic Uremic Syndrome (TTP–
HUS). He was initially treated with plasmapheresis and rituximab
and was started on peritoneal dialysis. About four weeks after his
presentation he experienced four generalized tonic-clonic (GTC)
seizures in a twenty-four hour period. He was treated with
levetiracetam for one week. Six months later he experienced two
more GTC seizures. MRIwas reported to show a ‘‘PRES pattern’’ and
EEGwas reported to show ‘‘FIRDA pattern’’ and hewas restarted on
levetiracetam. At that time hewas transferred to our institution for
further care.
Over the following eight months he experienced six episodes of
PRES, precipitated by elevated blood pressure and not associated
with metabolic abnormalities (such as uremia or electrolyte
abnormalities) or use of immunosuppressants. During these
episodes his blood pressures were elevated up to 200 over
100 mm of mercury, requiring transfer to the intensive care unit
and treatment with IV anti-hypertensives. The signiﬁcant eleva-
tions in his blood pressure were thought to be due to the patient’s
poor adherence to medications as well as the refractory nature of
his hypertension due to chronic renal failure requiring hemodial-
ysis. The onset of these episodes was consistently heralded by GTC
seizures, prompting treatment with anti-epileptic medications,
including valproic acid, phenytoin and levetiracetam. During someEpilepsy Association.
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Fig. 1. BrainMRI (FLAIR) done during a typical PRES episode showing vasogenic edema in the parieto-occipital areas (A), resolved 3months later (B). (C) A typical EEG obtained
during an episode of PRES, demonstrating slowing of the background rhythm to 3–4 Hz and posteriorly dominant independent bilateral PLEDs occurring at a frequency of
about 1 Hz. The two populations of PLEDs show distinct morphologies (with higher amplitude over the left hemisphere) and slightly different frequencies.
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polyopsia involving both visual ﬁelds. MRI of the brain obtained
during some of the episodes demonstrated T2 and FLAIR
hyperintensities in the bilateral parieto-occipital regions with
extension into the temporal lobes, with diffusion weighted
imaging showing scattered areas of restricted diffusion in the
posterior regions (Fig. 1A). These changes resolved after each PRES
episode, with the most recent brain MRI done when patient had
normal mental status showing scattered subcortical T2 and FLAIR
hyperintensities (Fig. 1B). He also had several EEGs performed
during the above-described PRES episodes which showed slowing
of the posterior background rhythm and posteriorly-dominant
bilateral independent PLEDs, more prominent over the left
hemisphere (Fig. 1C). At times PLEDs were occurring synchro-
nously, suggestive of generalized periodic epileptiform discharges
(GPEDs). Prolonged EEG monitoring as well as outpatient routine
EEGs completed after the PRES episodes demonstrated resolution
of PLEDs and normalization of the posterior background which
coincided with improvement in his mental status.
In the six months following the last PRES episode, he has been
maintained on oral antihypertensive agents and levetiracetam
1000 mg twice daily with an additional 500 mg taken after
hemodialysis. He has subsequently experienced several GTC
seizures that were not associated with elevated blood pressures
or prolonged postictal confusion.
3. Discussion
In 1996 Hinchey et al.1 described a reversible posterior
encephalopathy syndrome in thirteen patients with renal insufﬁ-
ciency, hypertension or immunosuppressed state. The transient
clinical ﬁndings included headaches, vomiting, confusion, seizures
and cortical blindness. Imaging of the brain showed extensive
bilateral white-matter edema in the posterior regions of thecerebral hemispheres. Over the years imaging ﬁndings associated
with the syndrome have been well described, but EEG ﬁndings
remain less well described. EEG ﬁndings seen in PRES described in
the literature include generalized and posterior focal slowing with
epileptiform discharges.2 There are also case reports of patients
presenting with status epilepticus with seizures in the parieto-
occipital area.3 We were only able to ﬁnd two reports of PLEDs
associated with PRES.4,5 PLEDs were described by Chatrian et al. in
19636 in patients with epilepsy, infarcts, alcoholism and systemic
infections. They are always an abnormal electrographic ﬁnding,
indicative of a focal or diffuse dysfunction of the cerebral cortex.
Our patient had bilateral independent PLEDs that were posterior
dominant, correlating with the posterior pathology occurring in
PRES. The left-sided discharges showed larger amplitudes, despite
the symmetrical appearance of imaging abnormalities.
It is important to be aware of the association of PRESwith PLEDs
and recurrent seizures. Patients presenting with PRES and mental
status changes should be further evaluated with an EEG, and if
PLEDs are seen treatment with an antiepileptic medication should
be considered in the acute setting. While most patients with PRES
recover fully and do not experience further seizures, there are rare
instances of patients developing epilepsy7 or experiencing a repeat
episode of PRES.3,8,9 Our patient is atypical as he had multiple
episodes of PRES, had documented PLEDs and he developed
epilepsy, requiring meticulous treatment with anti-hypertensive
and anti-epileptic medications. He had several risk factors for the
development of PRES, including end-stage renal disease requiring
hemodialysis, non-adherence to medications and poorly con-
trolled hypertension, as well as treatment with rituximab at the
time of the initial episode of PRES. We propose that patients with
PRES and PLEDs should have their blood pressure aggressively
controlled and they should have prolonged EEG monitoring. Anti-
epileptic medications should be considered and offered to patients
with PRES and PLEDs on a case by case basis. Treating the cause of
V. Skiba et al. / Seizure 20 (2011) 93–95 95PRES is important to prevent recurrent episodes. Each PRES
episode should be treated with anti-hypertensive agents or
removing the precipitating cause. Although PRES is typically
thought of as a reversible syndrome, this case illustrates that
recurrent episodes PRES, especially if associated with PLEDs, may
have serious long term sequelae. This case highlights the
importance of aggressive management and prevention of PRES
as well as the prevention of seizures as patients may develop
permanent brain dysfunction.
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